Parkinson Disease Clinical Trials in Birmingham, Alabama

8 studies are recruiting for parkinson disease in Birmingham, Alabama right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

    A study to determine if BHV-8000 is efficacious, safe and tolerable in adults diagnosed with early Parkinson's disease. The study will consist of a 48-week double-blind treatment phase followed by a 48-week open-label phase.

    Stage
    Phase 2
    Ages
    40 to 80
    Site
    Site-049, Birmingham, Alabama
    Locations
    22 in total
    Run by
    Biohaven Therapeutics Ltd.

    See if you can join NCT06976268 on ClinicalTrials.gov

  2. The University of Alabama at Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy

    The primary objective of this substudy is to measure the concentration and the regional brain distribution of activated brain microglia/macrophages using the PET ligand [18F]DPA-714 in participants enrolled in the UAB Innate and Adaptive Immunity in Parkinson's Disease (Clinical Research Core) and …

    Stage
    Phase 1
    Ages
    30 and older
    Site
    UAB Advanced Imaging Facility, Birmingham, Alabama
    Run by
    University of Alabama at Birmingham

    See if you can join NCT03457493 on ClinicalTrials.gov

  3. Longitudinal TSPO PET Imaging With [18F]DPA-714 in PPMI (PPMI DPA-714 PET Imaging)

    The overall goal of this protocol is to investigate [18F]DPA-714 binding in prodromal and early manifest Parkinson's Disease (PD) and to determine the baseline and change from baseline in [18F]DPA-714 binding in PD participants during a 24-month interval. Primary Objectives * To compare [18F]DPA-71…

    Stage
    EARLY_Phase 1
    Ages
    18 to 99
    Site
    UAB, Birmingham, Alabama
    Run by
    University of Alabama at Birmingham

    See if you can join NCT06289582 on ClinicalTrials.gov

  4. PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

    The Parkinson Progression Marker Initiative (PPMI) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest…

    Stage
    Not phased
    Ages
    30 and older
    Site
    University of Alabama at Birmingham, Birmingham, Alabama
    Locations
    50 in total
    Run by
    Michael J. Fox Foundation for Parkinson's Research

    See if you can join NCT04477785 on ClinicalTrials.gov

  5. Black and African Americans Connections to Parkinson's Disease (BLAAC PD)

    BLAAC PD is a research study to understand what Parkinson's disease looks like for Black and African American communities. BLAAC PD is happening at research centers around the United States. The study is part of the Global Parkinson's Genetics Program (GP2). GP2 is a research project working to tra…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Alabama at Birmingham, Birmingham, Alabama
    Locations
    12 in total
    Run by
    Michael J. Fox Foundation for Parkinson's Research

    See if you can join NCT06719583 on ClinicalTrials.gov

  6. Sensory Filtering in the Human Basal Ganglia as a Mechanism of Parkinson's Disease

    The investigators are investigating the brain activity associated with sensory information in movement disorders in order to improve treatment of these symptoms beyond what is currently available.

    Stage
    Not phased
    Ages
    18 to 89
    Site
    The University of Alabama at Birmingham Hospital, Birmingham, Alabama
    Run by
    University of Alabama at Birmingham

    See if you can join NCT05482126 on ClinicalTrials.gov

  7. Investigating Inhibitory Control Networks in Parkinson's Disease

    The purpose of this study is to investigate the brain activity associated with non-motor symptoms of movement disorders, including Parkinson's disease and essential tremor. These movement disorders commonly have significant non-motor features also, including depression, cognitive impairment, decrea…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Alabama at Birmingham, Birmingham, Alabama
    Run by
    University of Alabama at Birmingham

    See if you can join NCT04735458 on ClinicalTrials.gov

  8. Stimulus-Evoked Directional Field Potentials to Guide Subthalamic and Pallidal DBS for PD

    Our goal is to better understand how DBS modifies local neuronal activity and to pioneer device technologies that can record local DBS-evoked potentials (DLEPs) to guide therapy. Our vision is for a patient's unique electrophysiology to guide both electrode targeting during surgery and programming …

    Stage
    Not phased
    Ages
    18 to 89
    Site
    University of Alabama at Birmingham, Birmingham, Alabama
    Run by
    University of Alabama at Birmingham

    See if you can join NCT06169852 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.